W001 Hands-on: Innovative Suture Techniques Update
DESCRIPTION
This session combines an extensive lecture/video presentation with hands on instruction and practice sessions. Learn how to perform novel closure techniques that you did not know you could not live without. You will see a drawing and high quality video of these techniques that allow you to close wounds using minimal tension and therefore improve cosmetics. Next you will practice these techniques with our expert faculty. This activity has been approved by the American Board of Dermatology (ABD) for up to 30 Continuous Certification Program (CCP) Component 2 Self-Assessment points. For more information about CCP, please visit the ABD website at www.abderm.org.
LEARNING OBJECTIVES
Apply new methods to existing suturing techniques.
Utilize novel variations of existing suture techniques
Appreciate the value of reducing tension by applying new suture techniques
DIRECTOR
Cyndi Jill Yag-Howard, MD, FAAD
CO-DIRECTOR
Andrew Hart Weinstein, MD, MPH, FAAD
SPEAKERS
Charles Dunn, MD
Jonathan Kantor, MD, FAAD
Ashley Wysong, MD, MS, FAAD
HANDOUTS
DISCLOSURES
Charles Dunn, MD
No financial relationships exist with ineligible companies.
Jonathan Kantor, MD, FAAD
Apogee Therapeutics – Investigator(Grants/Research Funding); Eli Lilly and Company – Investigator(Grants/Research Funding); McGraw-Hill Companies – Other(Patent royalties or other compensation for Intellectual Property Rights); Verrica Pharmaceuticals Inc – Investigator(Grants/Research Funding);
Andrew Hart Weinstein, MD, MPH, FAAD
Dermatology Times (MMM MultiMedia Medical, LLC) – Consultant (1099 relationship)(Honoraria); Leo Pharma Inc. – Speaker(Fees); Max AI – Independent Contractor(Fees); MedX Health – Advisory Board(Honoraria); NuVida Medical – Advisory Board(Honoraria); Organogenesis, Inc. – Speaker(Fees); Regeneron – Speaker(Fees); Sensus Healthcare – Advisory Board(Honoraria); Sun Pharmaceutical Industries Ltd. – Advisory Board(Honoraria); Verrica Pharmaceuticals Inc – Advisory Board(Honoraria);
Ashley Wysong, MD, MS, FAAD
No financial relationships exist with ineligible companies.
Cyndi Jill Yag-Howard, MD, FAAD
Arthrex Corporation – Consultant (1099 relationship)(Honoraria);